Extensive pharmacological studies suggest that quercetin alleviates NAFLD through AMPK-mediated mitophagy, improving inflammation, oxidative stress, and lipid metabolism [30,31]. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.